Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Overview
Henry Schein (HSIC) is a global powerhouse in the provision of health care products and services, servicing office-based dental, medical, and animal health practices. As a company with expansive reach in the health care distribution and medical supply sectors, Henry Schein leverages a centralized, automated distribution network to offer an extensive inventory that includes thousands of branded items alongside its own private-label products. With a focus on operational efficiency and quality care, Henry Schein remains a trusted partner for practitioners, dental laboratories, government, and institutional health care clinics worldwide.
Comprehensive Product and Service Portfolio
At its core, Henry Schein delivers more than just products; it provides a suite of integrated solutions designed to support and streamline clinical operations. The company’s portfolio spans a wide array of product categories including dental supplies, medical instruments, and animal health products. In addition, Henry Schein supports its customers with value-added services, practice management solutions, and innovative technologies that assist in optimizing operational success and enhancing clinical outcomes.
Technology Integration and Centralized Distribution
Central to Henry Schein's strategy is its robust, technology-driven approach which employs a centralized distribution network. This system not only ensures rapid and reliable delivery of essential medical supplies but also supports the high-volume inventory management necessary to meet the dynamic demands of global health care providers. By integrating advanced technology, the company facilitates streamlined order fulfillment, efficient supply chain management, and improved access to cutting-edge practice solutions.
Market Position and Competitive Landscape
Henry Schein holds a significant market position as one of the foremost providers in its industry. Its extensive global network, underscored by affiliations with major financial indexes and a comprehensive supplier ecosystem, positions it uniquely among its competitors. The company's scale, combined with its operational expertise, allows it to address complex logistical challenges and cater to diverse customer needs across various care settings. This makes Henry Schein a pivotal player in the competitive landscape of health care services and products.
Strategic Acquisitions and Innovation
The company’s portfolio has been further enhanced through strategic acquisitions. An example is its integration of specialized providers, such as the recent acquisition of a company with expertise in Continuous Glucose Monitors (CGM), which complements its broad product offering. Such moves reflect Henry Schein's commitment to innovation and comprehensive care solutions, strengthening its ability to serve diverse practice areas with tailored, technologically advanced products.
Operational Excellence and Value Proposition
Henry Schein’s primary value proposition lies in its dual commitment to quality and efficiency. The company excels in offering a seamless blend of extensive product inventory and integrated service solutions, ensuring that healthcare professionals can focus on delivering superior patient care. The reliance on an efficient distribution network, coupled with ongoing investment in technology, underscores the company’s role as a critical enabler for operational excellence within the health care sector.
Expertise and Industry Knowledge
With decades of experience, Henry Schein has cultivated deep expertise in the intricacies of health care supply chains. Its ability to manage a vast network and deliver specialized products across multiple practice areas is a testament to its operational sophistication. The company’s approach is rooted in a profound understanding of the challenges faced by healthcare providers, and its service model is crafted to address these challenges head on with credible, reliable, and expertly managed solutions.
In Summary
Henry Schein remains a formidable force in the health care product and service sector by continuously evolving to meet the needs of a diverse client base. Its strategic integration of technology, commitment to quality, and expansive product portfolio not only support clinical practices but also enhance overall customer experience. For investors and market analysts, Henry Schein stands out as a company with a solid operational foundation, leveraging a synergy of comprehensive solutions, strategic acquisitions, and a technology-first approach to maintain its influential market presence.
Henry Schein (NASDAQ: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, has announced its upcoming first quarter 2025 financial results release. The company will disclose its Q1 2025 results before market opening on Monday, May 5th, 2025, followed by a live earnings conference call at 8:00 a.m. ET.
The earnings call will feature presentations from Stanley M. Bergman, Chairman of the Board and CEO, and Ronald N. South, Senior Vice President and CFO. Investors can access the webcast at investor.henryschein.com/webcasts, with a replay available after the presentation.
Henry Schein (Nasdaq: HSIC), the leading provider of healthcare solutions for dental and medical practitioners, has received validation for its net-zero science-based emissions reduction targets from the Science Based Targets initiative (SBTi).
The company's near-term commitments include:
- 42% reduction in absolute scope 1 GHG emissions by 2030 (2022 base year)
- Increasing renewable electricity sourcing from 0% to 100% by 2030
- 51.6% reduction in scope 3 GHG emissions per million USD value added by 2030
For long-term net-zero targets by 2050, Henry Schein commits to:
- 90% reduction in absolute scope 1 GHG emissions
- Maintaining 100% renewable electricity sourcing
- 97% reduction in scope 3 GHG emissions per million USD value added
Henry Schein (NASDAQ: HSIC) will showcase its comprehensive business and practice solutions at the 2025 International Dental Show (IDS) in Cologne, Germany, from March 25-29, 2025. The company will host media roundtable sessions titled 'Conversations with Henry Schein: Exploring the Present and Future of Oral Health' featuring discussions on digital dentistry's evolution.
Key highlights include:
- Presentation of 'Digital Workflow: 3-Click Dentistry' approach
- Launch of FDI's Consensus Statement on Electronic Health Records integration
- Display of comprehensive dental solutions including orthodontic treatments, endodontic products, dental handpieces, 3D printing solutions, and Henry Schein Brand consumables
- Hands-on endodontic courses led by industry experts Prof. Gianluca Gambarini and Dr. Nicola M. Grande
Henry Schein (HSIC), the world's largest provider of healthcare solutions for dental and medical practitioners, is supporting Special Olympics Healthy Athletes® screenings at the Special Olympics World Winter Games Turin 2025 (March 8-15, 2025) through product donations.
The company is providing essential oral health and medical supplies to support screenings across seven disciplines, including dentistry, podiatry, physiotherapy, preventive medicine, audiology, vision care, and mental health. This continues their partnership since 2018, which has supported programs in multiple countries. In 2023, HSIC provided $55,000 in supplies for the Berlin World Games.
The Healthy Athletes program, established in 1997, has delivered over two million free health screenings and trained more than 300,000 healthcare professionals in adapted screening protocols for people with intellectual and developmental disabilities (IDD). The initiative is part of Henry Schein Cares, the company's global corporate citizenship program.
Henry Schein (NASDAQ: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, has been named one of the 2025 World's Most Ethical Companies® by Ethisphere for the 14th consecutive year since 2012.
The company is one of three honorees in the Healthcare Products industry among 136 total honorees across 19 countries and 44 industries. In 2024, Henry Schein demonstrated its commitment through significant corporate citizenship efforts, including:
- Donating over $22.6M in product and cash to various organizations
- Providing disaster relief support following Hurricanes Helene and Milton
- Launching Prevention Is Power™ campaign
- Implementing new data protection principles and AI systems guidelines
The 2025 World's Most Ethical Companies® Honorees outperformed a comparable index of global companies by 7.8 percentage points from January 2020 to January 2025.
Henry Schein (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, has announced its participation in the upcoming Leerink Global Healthcare Conference. The presentation is scheduled for March 11th, 2025, at 1:40 p.m. Eastern time at the W South Beach hotel in Miami.
Investors and interested parties can access the live webcast of the presentation through www.henryschein.com/IRwebcasts. Replay options will be made available on the company's website after the event.
Henry Schein Medical (Nasdaq: HSIC) has opened nominations for its 2025 Athletics and Schools Rising Star Award, celebrating National Athletic Training Month in March. The annual award, established in 2021, recognizes emerging athletic trainers with 1-5 years of experience who show strong career potential.
Three finalists will be selected by March 11, 2025, through peer nominations submitted by March 5, 2025. Public voting will occur on Henry Schein's social media platforms from March 19-25, 2025. The winner, to be announced on March 27, 2025, will receive a MARC PRO muscle stimulator and a Medi Kit™ MULE roller bag with athletic training supplies.
The previous year's award recipient was Aline Valiengo, Head Athletic Trainer and Director of Sports Medicine at Coconut Creek High School in Florida.
Henry Schein (Nasdaq: HSIC) reported its Q4 and full-year 2024 financial results, with Q4 GAAP diluted EPS of $0.74 and non-GAAP diluted EPS of $1.19. The company achieved Q4 operating cash flow of $204 million and full-year operating cash flow of $848 million, up $348 million from 2023.
For 2025, Henry Schein expects non-GAAP diluted EPS between $4.80 and $4.94 with mid-single digit Adjusted EBITDA growth and total sales growth of 2-4%. The company announced a new organizational structure with three reportable segments: Global Distribution and Value-Added Services ($10.8B annual sales), Global Specialty Products ($1.4B), and Global Technology ($0.6B).
Q4 total net sales were $3.2 billion, up 5.8% year-over-year, reflecting 5.5% internal growth. Full-year 2024 sales reached $12.7 billion, a 2.7% increase. The company recorded $37 million in restructuring costs in Q4, with activities expected to provide over $80 million in annual run-rate savings.
Henry Schein (Nasdaq: HSIC) announced that Stanley M. Bergman, Chairman of the Board and CEO, received the National Association of Wholesaler-Distributors (NAW) Dirk Van Dongen Lifetime Achievement Award. The recognition honors individuals who have demonstrated exceptional leadership, service, and engagement with NAW and the distribution community.
Bergman received the award at the 2025 NAW Executive Summit Gala on January 28 in Washington, D.C. The NAW represents the $8.2 trillion wholesale distribution industry, which employs over 6 million workers across 35,000 companies operating in nearly 150,000 locations throughout North America.
Give Kids A Smile (GKAS) program is celebrating its 23rd year of providing free oral healthcare to underserved children, with its 2025 national kick-off event at Meharry Medical College School of Dentistry. Since 2003, GKAS volunteers have served over 9.5 million children in the U.S.
In 2025, nearly 1,100 GKAS events are scheduled nationwide, expecting to serve approximately 325,500 underserved children through free oral health education, screenings, and preventive services. About 25,000 dental professionals will volunteer, supported by donations from Henry Schein (HSIC) and Colgate-Palmolive.
Henry Schein has contributed over $20 million in oral health care products since the program's inception. The initiative addresses a critical need, as CDC data shows 50% of children aged 6-9 years have had cavities, with lower-income children being twice as likely to have untreated cavities compared to higher-income households.
FAQ
What is the current stock price of Henry Schein (HSIC)?
What is the market cap of Henry Schein (HSIC)?
What is the primary business of Henry Schein?
How does Henry Schein support its customers?
What distinguishes Henry Schein in the competitive healthcare market?
How does Henry Schein generate its revenue?
What role does technology play in the company’s operations?
How are strategic acquisitions integrated into Henry Schein's business model?
Who are the main customers of Henry Schein?
How does Henry Schein ensure quality and operational efficiency?
